This is a routine shelf filing with no immediate trading implications. Monitor for future prospectus supplements that would indicate an actual offering, which could signal a change in capital allocation strategy or a need for funding.
GILD drugs
GILD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 7 $133.21entry
- T+1 · 3mo ago −0.11%α −0.08% · $133.06
- T+5 · 3mo ago +3.87%α +3.47% · $138.36
- T+20 · 2mo ago +13.35%α +13.75% · $151.00
- T+60 · 15d ago +27.84%α +29.97% · $170.29
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Gilead Sciences filed an automatic shelf registration statement (S-3ASR) on August 6, 2026, registering an indeterminate amount of debt securities, common stock, preferred stock, depositary shares, warrants, subscription rights, stock purchase contracts, and stock purchase units for potential future sale. The filing is a routine administrative step for a large, well-capitalized company, enabling it to access capital markets quickly when needed. No specific offering is being made at this time, and the registration fees are deferred under a pay-as-you-go basis.
Key Facts
- Gilead filed an S-3ASR on August 6, 2026, registering an indeterminate amount of various securities for potential future sale.
- The filing is a universal shelf registration, allowing Gilead to offer and sell securities from time to time on a delayed or continuous basis.
- Registration fees are deferred under Rules 456(b) and 457(r), meaning no immediate offering is being made.
- The company has a market cap of $163.6B and has filed 5 offering/registration documents in the last 24 months, indicating routine capital management.
- Net proceeds from any future sale would be used for general corporate purposes.
Financial Impact
No offering size or pricing is disclosed; this is a shelf registration with an indeterminate amount. The filing itself has no immediate financial impact.
Risk Factors
- Future offerings under this shelf could dilute existing shareholders if common stock is issued.
- The filing itself does not indicate any immediate capital need or distress.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3ASR Filing (Primary) | 0001104659-26-092110 |
| Document: tm2621295d2_ex25-1.htm | 0001104659-26-092110 |
| Document: tm2621295d1_ex-filingfees.htm | 0001104659-26-092110 |
| Document: tm2621295d2_ex5-1.htm | 0001104659-26-092110 |
| Document: tm2621295d2_ex23-1.htm | 0001104659-26-092110 |
| Document: 0001104659-26-092110-index-headers.html | 0001104659-26-092110 |
| Document: 0001104659-26-092110-index.html | 0001104659-26-092110 |
| Document: 0001104659-26-092110.txt | 0001104659-26-092110 |
Track record
30 reports on GILD
5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +22.38% at T+60 after the Aug 13, 2026 report. 5 of 8 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $167.58 Now $167.58 +0.00% settles Feb 16
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $167.71 Now $167.58 −0.08% settles Feb 12
- Nov 13, 20264d ago Court Ruling Bullish 4/10 Entry $170.99 Now $167.58 −1.99% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $168.08 Now $167.58 −0.30% settles Feb 11
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $170.87 Now $167.58 −1.93% settles Feb 8
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $169.32 Now $167.58 −1.03% settles Feb 5
- Nov 4, 202612d ago 144 Neutral 3/10 Entry $167.57 Now $167.58 +0.01% settles Feb 3
- Oct 30, 202617d ago 144 Neutral 3/10 Entry $170.33 Now $167.58 −1.61% settles Jan 29
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $170.68 Now $167.58 −1.82% settles Jan 28
- Oct 22, 202625d ago Institutional Cluster Bearish 4/10 Entry $156.04 Now $167.58 −7.40% settles Jan 21
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers